⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13720287 | 0.71 | — | — | |
| SCHEMBL10921462 | 0.67 | — | — | |
| SCHEMBL18808216 | 0.67 | — | — | |
| SCHEMBL19103606 | 0.67 | — | — | |
| SCHEMBL10377488 | 0.67 | — | — | |
| SCHEMBL21099190 | 0.67 | — | — | |
| SCHEMBL30732599 | 0.67 | — | — | |
| SCHEMBL15436049 | 0.67 | — | — | |
| SCHEMBL6566171 | 0.67 | — | — | |
| SCHEMBL28223506 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005066129-A2 | BIS-PYRIDINO CONTAINING COMPOUNDS FOR USE IN THE TREATMENT OF CNS PATHOLOGIES | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2005-07-21 | — | — | WO | claimed |
| EP-4328225-A1 | HETEROCYCLIC DERIVATIVE INHIBITOR AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Shanghai Hansoh Biomedical Co., Ltd. (CN) | 2024-02-28 | — | — | EP | disclosed |
| EP-4289833-A1 | TYK2 INHIBITOR COMPOUND CONTAINING BICYCLIC RING | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023116779-A1 | DIALKYNE COMPOUND AND USE THEREOF | 上海艾力斯医药科技股份有限公司 | 2023-06-29 | — | — | WO | disclosed |
| CN-110997670-B | [1,2,4] triazolo [4,3-a ] pyridyl substituted indole compounds | 百时美施贵宝公司 | 2022-11-01 | — | — | CN | disclosed |
| US-11174264-B2 | TYK2 inhibitors and uses thereof | NIMBUS LAKSHMI, INC. (US) | 2021-11-16 | — | — | US | disclosed |
| EP-3366674-B1 | PYRIDINE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2020-12-23 | — | — | EP | disclosed |
| US-20200231594-A1 | TYK2 INHIBITORS AND USES THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-07-23 | — | — | US | disclosed |
| EP-2977378-B1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO LTD (KR) | 2020-06-10 | — | — | EP | disclosed |
| WO-2019008025-A1 | NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS | INFLAZOME LIMITED (IE) | 2019-01-10 | — | — | WO | disclosed |
| EP-1403338-B1 | Black ink for ink-jet recording | FUJIFILM CORP (JP) | 2008-03-26 | — | — | EP | disclosed |
| US-20070281937-A1 | Ion Channel Modulators | SCION PHARMACEUTICALS, INC. | 2007-12-06 | — | — | US | disclosed |
| US-20070238871-A1 | Glycolipids And Analogues Thereof As Antigens For NKT Cells | THE ROCKEFELLER UNIVERSITY (US) | 2007-10-11 | — | — | US | disclosed |
| US-20070238871-A1 | Glycolipids And Analogues Thereof As Antigens For NKT Cells | THE ROCKEFELLER UNIVERSITY (US) | 2007-10-11 | — | — | US | disclosed |
| EP-1804826-A2 | TREATMENT OF NEUROLOGICAL DEFICITS IN THE STRIATUM OR SUBSTANTA NIGRA PARS COMPACTA | ETHICON, INC. (US) | 2007-07-11 | — | — | EP | disclosed |
| EP-1792893-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-06-06 | — | — | EP | disclosed |
| EP-1757610-A1 | CONDENSED PYRIMIDINE DERIVATIVE AND XANTHINE OXIDASE INHIBITOR | Nippon Chemiphar Co., Ltd. (JP) | 2007-02-28 | — | — | EP | disclosed |
| WO-2006036919-A2 | TREATMENT OF NEUROLOGICAL DEFICITS IN THE STRIATUM OR SUBSTANTA NIGRA PARS COMPACTA | ETHICON, INC. (US) | 2006-04-06 | — | — | WO | disclosed |
| WO-2005077377-A1 | COMPOSITIONS THAT INCLUDE A TRITERPENE AND A CARRIER | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2005-08-25 | — | — | WO | disclosed |
| WO-2002094378-A2 | INCREASED FUNCTIONAL ACTIVITY AND/OR EXPRESSION OF ABC TRANSPORTERS PROTECTS AGAINST THE LOSS OF DOPAMINE NEURONS ASSOCIATED WITH PARKINSON'S DISEASE | ACTIVE PASS PHARMACEUTICALS, INC. (CA) | 2002-11-28 | — | — | WO | disclosed |